Pfizer’s Chief Executive Officer Albert Bourla sold shares in the company worth $5.6 million on the day the drugmaker announced that its CCP virus vaccine was more than 90 percent effective, which caused Pfizer stock to surge.
Bourla sold 132,508 shares at $41.94 a share, amounting to 62 percent of his holding of Pfizer stock, according to filings with the U.S. Securities and Exchange Commission (SEC). Pfizer shares traded as high as $41.99 on Nov. 9, the day the company announced interim trial results showing its experimental vaccine for the CCP (Chinese Communist Party) virus was highly effective in preventing infection.